WeSearch

CJP founder Abhijeet Dipke diagnosed with typhoid, says agitation will continue

·2 min read · 0 reactions · 0 comments · 7 views
#politics#education#protest
CJP founder Abhijeet Dipke diagnosed with typhoid, says agitation will continue
TL;DR · WeSearch summary

CJP founder Abhijeet Dipke has been diagnosed with typhoid but vows to continue the agitation seeking Union Education Minister Dharmendra Pradhan's resignation. Dipke thanked CJP supporters for keeping the protests alive across the country and expressed confidence that sustained peaceful protests would help achieve their key demand. The CJP-led agitation has been demanding accountability in the examination system, reforms in recruitment and entrance tests, and Pradhan's resignation.

Key facts
About this source

Hindustan Times — Top publishes from India and files mainly under world. We currently carry 1,588 of its stories.

Original article
Hindustan Times — Top
Read full at Hindustan Times — Top →
Opening excerpt (first ~120 words) tap to expand

HomeNextCJP founder Abhijeet Dipke diagnosed with typhoid, says agitation will continueCJP founder Abhijeet Dipke diagnosed with typhoid, says agitation will continuePublished on: Jul 25, 2026, 10:46:39 ISTPTIPrefer HTon GoogleShare viaCopy link New Delhi, Cockroach Janta Party founder Abhijeet Dipke on Saturday said he had been diagnosed with typhoid but vowed that his illness would not slow the movement seeking Union Education Minister Dharmendra Pradhan's resignation.CJP founder Abhijeet Dipke diagnosed with typhoid, says agitation will continueIn a video message shared on social media, Dipke said he had been unwell for the past few days and was currently undergoing treatment.Despite his illness, he thanked CJP supporters for keeping the protests alive across the country and said that…

Excerpt limited to ~120 words for fair-use compliance. The full article is at Hindustan Times — Top.

Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments